Repligen (RGEN) Total Liabilities (2011 - 2026)
Repligen (RGEN) posted quarterly Total Liabilities of $838.1 million for Q2 2026, little changed year-over-year from $839.9 million in Q2 2025, and up 1.56% quarter-over-quarter from $825.3 million in Q1 2026.
Repligen (RGEN) Total Liabilities (2011 - 2026) Analysis & Trends
Repligen (RGEN) has reported Total Liabilities for 16 consecutive years, with $838.1 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Total Liabilities changed 0.21% year-over-year to $838.1 million; the TTM figure through Jun 2026 stood at $838.1 million (changed 0.21% YoY), while the FY2025 annual figure was $843.6 million, down 1.56% from the prior year.
- Total Liabilities climbed to $838.1 million in Q2 2026 per RGEN's latest filing, from $825.3 million in the prior quarter.
- Across five years, Total Liabilities topped out at $888.1 million in Q1 2024 and bottomed at $549.0 million in Q3 2023.
- Historically, Total Liabilities has averaged $757.6 million across 5 years, with a median of $831.7 million in 2026.
- Annual changes were most pronounced in 2022 — Total Liabilities surged 66.37% — and 2023, when it decreased 12.5%.
- Repligen's Total Liabilities stood at $620.9 million in 2022, then jumped by 39.53% to $866.3 million in 2023, then slipped by 1.08% to $856.9 million in 2024, then retreated by 1.56% to $843.6 million in 2025, then dropped by 0.64% to $838.1 million in 2026.
- Business Quant data shows RGEN's Total Liabilities at $838.1 million in Q2 2026, $825.3 million in Q1 2026, and $843.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 2.58 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 50.73 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 9.50 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 2.38 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 20.27 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 1.09 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 9.44 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 4.24 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 13.61 Bn |
| 10 | Repligen | 10.25 Bn | 9.24 Bn | 110.04 Mn | 838.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 838.15 Mn |
| Mar 31, 2026 | 825.31 Mn |
| Dec 31, 2025 | 843.57 Mn |
| Sep 30, 2025 | 840.62 Mn |
| Jun 30, 2025 | 839.89 Mn |
| Mar 31, 2025 | 866.66 Mn |
| Dec 31, 2024 | 856.95 Mn |
| Sep 30, 2024 | 813.96 Mn |
| Jun 30, 2024 | 881.57 Mn |
| Mar 31, 2024 | 888.10 Mn |
| Dec 31, 2023 | 866.34 Mn |
| Sep 30, 2023 | 548.99 Mn |
| Jun 30, 2023 | 600.20 Mn |
| Mar 31, 2023 | 621.23 Mn |
| Dec 31, 2022 | 620.90 Mn |
| Sep 30, 2022 | 627.42 Mn |
| Jun 30, 2022 | 639.55 Mn |
| Mar 31, 2022 | 617.42 Mn |
| Dec 31, 2021 | 608.29 Mn |
| Sep 30, 2021 | 526.13 Mn |